Article
Medicare ‘Advantage’ and the Push for Full Privatization
Explore the impact of the Medicare Advantage system and its potential expansion under a second term of the Trump administration.
Private Equity
Article
Private Equity’s Wish List
Explore how the private equity industry influenced the 2024 election and its plans for accessing retirement funds. Find out what policy changes are expected in the second Trump term.
Article
Medicare “Advantage” By the Numbers
Examining the hidden side of Medicare Advantage: uncover how private insurance companies are profiting at the expense of seniors.
Issue Brief
Stop Wall Street Looting Act: More Necessary Now Than Ever
CEPR co-director Eileen Appelbaum has written a letter to Senator Elizabeth Warren explaining the dangers of private equity.
Report
Comment from Private Equity Stakeholder Project/Center for Economic Policy & Research
Learn how the private equity industry is contributing to the rising medical debt and the importance of accountability in healthcare.
Report
Structural Determinants of Health: Hospitals’ Unequal Capital Investments Drive Health Inequities
Discover how the structural determinants of health inequity in the US can lead to disparities in healthcare access and outcomes.
Article
Warren’s New Bill Makes Private Equity’s Death Grip on Hospitals a Crime
Investigating private equity in healthcare. Learn how lax regulations allowed corporate owners to profit while driving hospitals to financial disaster.
Article
University Endowment Returns Don’t Measure Up
The debate around university endowment funds and their investment decisions. Is it possible to shield investments from political pressures?
Report
CEPR Comments to FTC, DOJ, HHS on Consolidation in Health Care Markets
Explore the impact of private equity in healthcare. Learn about the influence of Wall Street on the healthcare industry and its implications.
Statement: Final Merger Guidelines by the U.S. Federal Trade Commission and the U.S. Department of Justice
The guidelines provide a clear roadmap to antitrust agencies and courts to prevent further industry consolidation in markets already dominated by a few large firms.
